Technical analysis of Amgen Inc. (AMGN): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience.
Price Performance
| 1 month | +15.62% |
| 3 months | +23.00% |
| Year-to-date | +42.38% |
| 1 year | +56.15% |
| 3 years | +74.80% |
| 5 years | +117.50% |
| 10 years | +244.63% |
52-Week Range
| 52-week High | $475.64 |
| 52-week Low | $288.00 |
| Avg Volume (90d) | 2.6M |
Technical Indicators
| SMA 50 | $419.96 |
| SMA 200 | $374.79 |
| Beta | 0.47 |
| 30-day Volatility (annualised) | 27.0% |
| Price vs SMA 50 | +11.0% |
| Price vs SMA 200 | +24.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $327.31 | |
| 2026-01 | $341.88 | +4.5% |
| 2026-02 | $388.16 | +13.5% |
| 2026-03 | $351.85 | -9.4% |
| 2026-04 | $346.25 | -1.6% |
| 2026-05 | $336.79 | -2.7% |
| 2026-06 | $362.12 | +7.5% |
| 2026-07 | $385.16 | +6.4% |
| 2026-08 | $429.88 | +11.6% |
| 2026-09 | $421.51 | -1.9% |
| 2026-10 | $466.01 | +10.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-03 | $5.79 | $10.07B |
| 2026-08-04 | $5.62 | $9.43B |
| 2026-04-30 | $4.77 | $8.58B |
| 2026-02-03 | $4.73 | $9.47B |
| 2025-11-04 | $5.02 | $8.97B |
| 2025-08-05 | $5.28 | $8.94B |
| 2025-05-01 | $4.27 | $8.06B |
Price
| Price | $466.01 (closing price, October 30, 2026) |
| Market Cap | $251.9B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 28.96 |
| Price / Book | 21.53 |
| EV / EBITDA | 16.75 |
| Dividend Yield | 2.13% |
Financial Health
| Debt / Equity | 4.90 |
| Current Ratio | 1.37 |
| Piotroski F-Score | 8 |
| Altman Z-Score | 1.74 |